medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 1

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (1)

Associated factors of treatment failure in people living with HIV taking antiretroviral treatment: a scooping review

del Moral TLE, Silva BG, Campos-Uscanga Y

Language: Spanish
References: 32
Page:
PDF size: 444.92 Kb.


ABSTRACT

Introduction: It is estimated that by 2019 there are 38 million people living with the human immunodeficiency virus (HIV), for whom antiretroviral treatment is essential. Treatment failure occurs when there is a progression of the disease in clinical, virological, or immunological parameters that lead to a change in treatment and a worse prognosis of the disease. The objective of this panoramic review is to answer the following question: What are the factors associated with the therapeutic failure of antiretroviral treatment in people living with HIV? Methods: A panoramic review was carried out following the guidelines for systematic reviews suggested by PRISMA-SCR (Preferred Reporting Items for Systematic Reviews and Meta-Analyzes extension for Scoping Reviews) and modified by Tricco et al. The articles on therapeutic failure in the adult population on the first line of ART were rescued from PubMed and the Virtual Health Library (VHL). The search was limited to a period from 2010 to 2020 and articles whose population was children or pregnant women and articles not available in English or Spanish were excluded. Information, Analysis and Synthesis: The definition of therapeutic failure used corresponds to the WHO criteria in eight articles, while the rest use the virological criterion in variable reference points. Regarding the factors associated with treatment failure, those with statistical significance grouped into sociodemographic factors (sex, age, age of ART onset, shared HIV status, injection drug use, and educational level) and clinical factors (T CD4+ levels are described at the start of ART, level of adherence, change of regimen, WHO stage at the start of ART, and tuberculosis coinfection). Conclusions: Two fundamental factors in therapeutic failure are sociodemographic and clinical, which in turn depend on accessibility to treatment, the health system and intrinsic characteristics of the individuals and the behaviors they adopt in relation to their disease.


REFERENCES

  1. ONUSIDA. Hoja informativa - Últimas estadísticas sobre el estado de la epidemia de sida. ONUSIDA; 2020. [Acceso 10/04/2021]. Disponible en: Disponible en: https://www.unaids.org/es/resources/fact-sheet/2019 , https://www.Unaids.Org/Es/Resources/Fact-Sheet/2018-2020

  2. Nachega B, Marconi C, van Zyl U, Gardner M, Preiser W, Hong Y, et al. HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts. Infect Disord Drug Targets. 2012[Acceso 10/04/2021];11:167-74. Disponible en: Disponible en: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1871-5265&volume=11&issue=2&spage=167

  3. Aldous JL, Haubrich RH. Defining Treatment Failure in Resource-Rich Settings Jeannette. Natl Institutes Health. 2010[Acceso 10/04/2021];459-66. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/20048711/

  4. World Health Organization. Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitioins for surveillance. 2005. [Acceso 10/04/2021]. Disponible en: Disponible en: https://apps.who.int/iris/handle/10665/69058

  5. Aveyard H. Doing a Literature Review in Health and Social Care. vol. 3. Mc Graw Hill Education. 2014. [Acceso 10/04/2021]. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/27712339/

  6. Tricco AC, Lillie E, Zarin W, O'Brien K, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018[Acceso 10/04/2021];169:467-73. Disponible en: https://www.acpjournals.org/doi/10.7326/M18-0850

  7. Richardson ET, Grant PM, Zolopa AR. Evolution of HIV treatment guidelines in high- and low-income countries: Converging recommendations. Antiviral Res. 2014;103:88-93. DOI: http://dx.doi.org/10.1016/j.antiviral.2013.12.007

  8. Haftu AZ, Aregay A, Id D, Bezabih NM, Woldearegay W. Incidence and factors associated with treatment failure among HIV infected adolescent and adult patients on second-line antiretroviral therapy in public hospitals of Northern Ethiopia: Multicenter retrospective study. PLoS One. 2020;15(9 September):1-15. DOI:http://dx.doi.org/10.1371/journal.pone.0239191

  9. Desta A, Wubayehu T, Nesredin F, Teame G, Gebremedhn G, Aregay A, et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: A retrospective study. BMC Infect Dis. 2020[Acceso 10/04/2021];20(1):1-10. Disponible en: Disponible en: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-4732-6

  10. Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, et al. Incidence and predictors of virological failure among adult HIV patients on first- line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020Dec [Acceso 10/04/2021];20(1):460. Disponible en: Disponible en: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05177-2

  11. Assemie MA, Alene M, Ketema DB, Mulatu S. Treatment failure and associated factors among first line patients on highly active antiretroviral therapy in Ethiopia: a systematic review and meta-analysis. Glob Heal Res Policy. 2019;4(1):32. DOI:https://doi.org/10.1186/s41256-019-0120-4

  12. Chawana T, Gavi S, Reid A, Bwakura T Nhachi CFB. Factors Influencing Treatment failure in HIV Positive Adult Patients on First Line Antiretroviral Therapy. Cent Afr J Med. 2014[Acceso 10/04/2021];60(5-8):29-36. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/26867253/

  13. Ayele G, Tessema B, Amsalu A, Ferede G, Yismaw G. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia. BMC Immunol. 2018;19:37. DOI:https://doi.org/10.1186/s12865-018-0278-4

  14. Cesar C, Jenkins C, Shepherd B, Padgett D, Mejía F, Rocha S, et al. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in Latin America and the Caribbean: an observational cohort study. Lancet. 2012;2(11):e492. DOI: https://doi.org/10.1016/S2352-3018(15)00183-6

  15. Rupérez M, Pou C, Maculuve S, Cedeño S, Luis L, Rodríguez J, et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrob Chemother. 2015;70(9):2639-47. DOI: https://doi.org/10.1093/jac/dkv143

  16. Yimer YT, Yalew AW. Magnitude and Predictors of Anti-Retroviral Treatment (ART) Failure in Private Health Facilities in Addis Ababa, Ethiopia. PLoS One. 2015 [Acceso 10/04/2021];10(5):e0126026. DOI: https://doi.org/10.1371/journal.pone.0126026

  17. De la Hoz J, Bolaño L, Cárdenas O, González R, Sabbag J, Palacio L, et al. Caracterización del fracaso terapéutico en pacientes VIH positivos en la región del Caribe. Colomb Med. 2014[Acceso 10/04/2021];45(4):162-7. Disponible en: Disponible en: http://www.scielo.org.co/scielo.php?pid=S1657-95342014000400004&script=sci_abstract&tlng=eshttp://www.scielo.org.co/scielo.php?pid=S1657-95342014000400004&script=sci_abstract&tlng=es

  18. Tran D, Wilson D, Shakeshaft A, Duc A, Doran C, Zhang L. Determinants of virological failure after 1 year' s antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces. BMJ Open. 2014 [Acceso 10/04/2021];90(7):538-44. DOI: https://doi.org/10.1136/sextrans-2013-051353

  19. Fong R, Cheng AC, Vujovic O, Hoy JF. Factors associated with virological failure in a cohort of combination antiretroviral therapy-treated patients managed at a tertiary referral centre. CSIRO. 2013 Nov;10(5):442-7. DOI: https://doi.org/10.1071/SH13043

  20. Khienprasit N, Chaiwarith R, Sirisanthana T, Supparatpinyo K. Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital. AIDS Res Ther. 2011 Nov;8(1):42. DOI: https://doi.org/10.1186/1742-6405-8-42

  21. Zhou J, Kumarasamy N, Boyd M, Chen YMA, Sirisanthana T. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD). Natl Institutes Health 2010 Jan;11(1):31-9. DOI: https://doi.org/10.1111/j.1468-1293.2009.00738.X

  22. Ahoua L, Guenther G, Pinoges L, Anguzu P, Chaix L, Tiec C, et al. Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda. BioMed Cent. 2009;9(81):1-11. DOI: https://doi.org/10.1186/1471-2334-9-81

  23. Endalamaw A, Mekonnen M, Geremew D, Yehualashet FA, Tesera H. HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis. BMC Public Health. 2020 Jan 20;20(1):82. DOI: https://doi.org/10.1186/s12889-020-8160-8

  24. Machado Alba JE, Guitart XV. Evaluación de la respuesta y seguridad a diferentes esquemas de tratamiento antirretroviral en Colombia. Rev Investig Andin. 2013[Acceso 10/04/2021];15(27):770-83. Disponible en: Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0124-81462013000200005

  25. Thu N, Harries A, Kumar A, Minn M, Yee W, Win T, et al. High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first- line ART in Myanmar, 2005-2015. PLoS One. 2017;12(2):e0171780. DOI: https://doi.org/10.1371/journal.pone.0171780

  26. Leierer G, Grabmeier K, Steuer A, Geit M, Sarcletti M, Haas B, et al. Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study. PLoS One. 2015;10(11):e0142923. DOI: https://doi.org/10.1371/journal.pone.0142923

  27. Bayou B, Sisay A, Kumie A. Assessment of the magnitude and associated factors of immunological failure among adult and adolescent HIV-infected patients in St. Luke and Tulubolo Hospital, Oromia Region, Ethiopia. Pan Afr Med J. 2015;21:291. DOI: https://doi.org/10.11604/pamj.2015.21.291.6831

  28. WHO. Clinical Guidelines: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 2016 recommendations for a public health approach. 2nd ed. Geneva: WHO; 2016. [Acceso 10/04/2021]. Disponible en: Disponible en: https://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf;jsessionid=02BB2B1A5F7CECBD5EEC4E8AE5E31F12?sequence=1

  29. Anderson SE, Whitaker RC. Association of Self-Regulation with Obesity in Boys vs Girls in a US National Sample. JAMA Pediatr. 2018 Sep;172(9):842-50. DOI: https://doi.org/10.1001/jamapediatrics.2018.1413

  30. Lansing AH, Berg CA. Topical review: Adolescent self-regulation as a foundation for chronic illness self-management. J Pediatr Psychol. 2014 Nov;39(10):1091-6. DOI: https://doi.org/10.1093/jpepsy/jsu067

  31. Akilimali PZ, Masika PM, Kashala EA, Kalambayi PK, Lepira FB, Beya PM, et al. Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a (post-) conflict setting: A retrospective cohort study from goma, Democratic Republic of Congo. PLoS One. 2017;12(2):e0171407. DOI: [url]https://doi.org/10.1371/journal.pone.0171407[/url] [/ref]

  32. Gutiérrez F. Infección por el VIH/sida: ¿El principio del fin de la primera gran pandemia contemporánea? Rev Clin Esp. 2017;217(8):468-72. DOI: https://doi.org/10.1016/j.rce.2017.04.004




2020     |     www.medigraphic.com